65
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction

, , , , , & show all
Pages 2261-2269 | Published online: 27 Jul 2018

References

  • ManninoDMBramanSThe epidemiology and economics of chronic obstructive pulmonary diseaseProc Am Thorac Soc20074750250617878461
  • van ManenJGBindelsPJIJzermansCJvan der ZeeJSBottemaBJSchadéEPrevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40J Clin Epidemiol200154328729311223326
  • García-RioFSorianoJBMiravitllesMImpact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary diseasePLoS One201498e10522025153331
  • CecereLMLittmanAJSlatoreCGObesity and COPD: associated symptoms, health-related quality of life, and medication useCOPD20118427528421809909
  • SchabergTReichertBSchülinTLodeHMauchHRapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid mediaEur Respir J1995810168816938586123
  • LandboCPrescottELangePVestboJAlmdalTPPrognostic value of nutritional status in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med199916061856186110588597
  • GuoYZhangTWangZBody mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysisMedicine (Baltimore)20169528e422527428228
  • ShinHYKangHTRecent trends in the prevalence of underweight, overweight, and obesity in Korean adults: the Korean National Health and Nutrition Examination Survey from 1998 to 2014J Epidemiol201727941341928420559
  • JoYSChoiSMLeeJThe relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010–2012Respir Med201510919610425434653
  • LeeYHYoonSJKimEJKimYASeoHYOhIHEconomic burden of asthma in KoreaAllergy Asthma Proc2011326354022221428
  • World Health OrganizationThe Asia-Pacific Perspective: Redefining Obesity and its TreatmentSydneyHealth Communications Australia2000
  • KimMKLeeWYKangJHCommittee of Clinical Practice Guidelines; Korean Society for the Study of Obesity2014 clinical practice guidelines for overweight and obesity in KoreaEndocrinol Metab (Seoul)201429440540925559568
  • ÇolakYAfzalSLangePNordestgaardBGHigh body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population StudyInt J Epidemiol20164551551155927118560
  • OngKCEarnestALuSJA multidimensional grading system (BODE index) as predictor of hospitalization for COPDChest200512863810381616354849
  • MarinJMCarrizoSJCasanovaCPrediction of risk of COPD exacerbations by the BODE indexRespir Med2009103337337819013781
  • LaunoisCBarbeCBertinEThe modified Medical Research Council scale for the assessment of dyspnea in daily living in obesity: a pilot studyBMC Pulm Med2012126123025326
  • RodríguezDAGarcia-AymerichJValeraJLPAC-COPD Study GroupDeterminants of exercise capacity in obese and non-obese COPD patientsRespir Med2014108574575124565602
  • LambertAAPutchaNDrummondMBCOPDGene InvestigatorsObesity is associated with increased morbidity in moderate to severe COPDChest20171511687727568229
  • GotoTTsugawaYFaridiMKCamargoCAJrHasegawaKReduced risk of acute exacerbation of COPD after bariatric surgery: a self-controlled case series studyChest2018153361161728716643
  • YooKHKimYSSheenSSPrevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008Respirology201116465966521342331
  • DecramerMCooperCBTreatment of COPD: the sooner the better?Thorax201065983784120805184
  • JeeSHSullJWParkJBody-mass index and mortality in Korean men and womenN Engl J Med2006355877978716926276
  • CaoCWangRWangJBunjhooHXuYXiongWBody mass index and mortality in chronic obstructive pulmonary disease: a meta-analysisPLoS One201278e4389222937118
  • VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
  • IschakiEPapatheodorouGGakiEPapaIKoulourisNLoukidesSBody mass and fat-free mass indices in COPD: relation with variables expressing disease severityChest2007132116416917505043
  • FranssenFMO’DonnellDEGoossensGHBlaakEEScholsAMObesity and the lung: 5. Obesity and COPDThorax200863121110111719020276
  • TomodaKYoshikawaMItohTElevated circulating plasma adiponectin in underweight patients with COPDChest2007132113514017625082
  • RheeCKKimKYoonHKNatural course of early COPDInt J Chron Obstruct Pulmon Dis20171266366828255237
  • VestboJPapiACorradiMSingle inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trialLancet2017389100821919192928385353
  • LipsonDABarnacleHBirkRFULFIL Trial: once-daily triple therapy for patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2017196443844628375647